The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven ...

President Donald Trump has claimed Kenvue’s pain reliever is a potential cause of autism, despite clear evidence.

The announcement comes weeks after President Trump made claims linking Tylenol to autism in pregnant women's unborn babies, ...

Kimberly-Clark, the maker of Huggies, is set to acquire Kenvue, the parent company of Tylenol, in a nearly $50 billion deal.

The owner of Kleenex and Huggies will acquire the company that has fought unproven claims by the Trump administration that a ...

Kimberly-Clark is laying down $40 billion to buy Kenvue in a massive deal that has puzzled some investors as the Tylenol ...

The lawsuit accuses pharmaceutical companies of “deceptively marketing” Tylenol as a safe option for pregnant mothers.

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer ...